Adora Ndu
Förmögenhet: 838 456 $ per 2026-06-30
Förmögenhet: 838 456 $ per 2026-06-30
Dr. Adora Ndu is an Independent Director at ACADIA Pharmaceuticals, Inc., a Chief Regulatory & Legal Officer at BridgeBio Pharma, Inc. and an Independent Director at DBV Technologies SA. She is on the Board of Directors at ACADIA Pharmaceuticals, Inc., DBV Technologies SA and Alliance for Regenerative Medicine.
Dr. Ndu was previously employed as a VP-World Wide Research & Development by BioMarin Pharmaceutical, Inc. and a Director-Medical Policy Development by US Food & Drug Administration.
She received her graduate degree from The University of Maryland Francis King Carey School of Law and a doctorate degree from Howard University College of Medicine.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-05-29 | 32 908 ( 0,02 % ) | 832 572 $ | 2026-06-30 | |
| 2026-04-15 | 1 825 ( 0 % ) | 5 884 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| DBV TECHNOLOGIES | Direktör/Styrelseledamot | 2021-05-19 |
| BRIDGEBIO PHARMA, INC. | Generell Rådgivare | 2022-01-01 |
| ACADIA PHARMACEUTICALS INC. | Direktör/Styrelseledamot | 2022-10-10 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Direktör/Styrelseledamot | - |
| Företag | Position | Slut |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-01-01 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Företagsledare/Principal | 2016-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
DBV Technologies SA
DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
The University of Maryland Francis King Carey School of Law
The University of Maryland Francis King Carey School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard University College of Medicine
Howard University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån